Autor: |
Hoffman M; Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Department of Physiotherapy, Alfred Health, Melbourne, VIC, Australia; Institute for Breathing and Sleep, Melbourne, VIC, Australia. Electronic address: mariana.hoffman1@monash.edu., Burge AT; Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Department of Physiotherapy, Alfred Health, Melbourne, VIC, Australia., Wong N; Monash Bioinformatics Platform, Monash University, Melbourne, VIC, Australia., McDonald CF; Institute for Breathing and Sleep, Melbourne, VIC, Australia; Respiratory and Sleep Medicine, Austin Health, Melbourne, VIC, Australia., Chambers DC; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia; Department of Thoracic Medicine, Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Australia., Glaspole I; Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Department of Respiratory and Sleep Medicine, Alfred Health, Melbourne, VIC, Australia., Mackintosh JA; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia; Department of Thoracic Medicine, Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Australia., Ekström M; Department of Clinical Sciences, Respiratory Medicine, Allergology, and Palliative Medicine, Lund University, Faculty of Medicine, Lund, Sweden., Sköld M; Department of Medicine Solna and Center for Molecular Medicine, Respiratory Medicine Unit, Karolinska Institutet, Stockholm, Sweden; Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden., Goh NSL; Institute for Breathing and Sleep, Melbourne, VIC, Australia; Respiratory and Sleep Medicine, Austin Health, Melbourne, VIC, Australia., Corte TJ; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia; The University of Sydney, Central Clinical School, Sydney, NSW, Australia., Holland AE; Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Department of Physiotherapy, Alfred Health, Melbourne, VIC, Australia; Institute for Breathing and Sleep, Melbourne, VIC, Australia. |
Abstrakt: |
Competing Interests: Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: M. H. reports a relationship with Thoracic Society of Australia and New Zealand that includes funding grants and relationship with Centre of Research Excellence in Pulmonary Fibrosis that includes travel reimbursement. I. G. reports a relationship with Boehringer Ingelheim Ltd that includes board membership, a relationship with Lassen Therapeutics 1, Inc, that includes consulting or advisory, a relationship with Tian Li that includes consulting or advisory, and a relationship with Avalyn Pharma Inc that includes consulting or advisory. J. A. M reports a relationship with Boehringer Ingelheim Ltd that includes speaking and lecture fees. N. S. L. G. reports a relationship with Boehringer Ingelheim GmbH that includes consulting or advisory and speaking and lecture fees. N. S. L. G. also reports a relationship with AstraZeneca Pharmaceuticals LP that includes speaking and lecture fees and a relationship with National Health and Medical Research Council that includes funding grants. T. J. C. declares a relationship with institutional grant Boehringer Ingleheim and Roche that includes advisory board and speaker fees, a relationship with Bristol Myers Squibb, Vicore, DevPro, Bridge Biotherapeutics that includes advisory board, and a relationship with Biogen, Galapagos, Avalyn Pharma that includes institutional grant funding. C. F. M., D. C. C., M. E., T. J. C., and A. E. H report administrative support was provided by BOC Australia. None declared (A. T. B., M. S.). |